Gingko Biloba

Quick links to important sections

Gingko Biloba

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Gingko Biloba

Property Description
Active ingredient Flavone glycosides, Terpene lactones (Ginkgolides, Bilobalide)
Form Tablet, capsule, liquid extract (Oral route)
Pharmacological class Phytomedicine, Vasoregulator, Nootropic Agent
Common use Supports memory and concentration, aids circulation
Origin Dried leaves of the Ginkgo biloba tree

What Type of Medicine is Standardized Ginkgo Biloba Extract?

Standardized Ginkgo biloba extract (GBE) is formally classified as a phytomedicine, which is a medicinal product derived directly from a plant source, placing it in the pharmacological classes of vasoregulator and nootropic agent. The active substance originates exclusively from the dried leaves of the Ginkgo biloba tree. Unlike general herbal preparations, GBE is characterized by a consistent composition.

Standardized Ginkgo biloba extract is classified as a traditional herbal medicinal product, intended for supporting cognitive performance. The extract is typically formulated for the oral route, available as tablets, capsules, or liquid extracts, intended primarily for the adult and geriatric populations seeking support for circulatory and cognitive health.

Active Ingredients: The Composition and Standardization of Ginkgo

The active constituents defining the quality of Ginkgo biloba extract are a precise mixture of flavone glycosides and terpene lactones, including specific ginkgolides and bilobalide. These compounds are obtained using a controlled hydro-ethanolic solvent for extraction. Standardization is critical to the identity of GBE; it dictates that the final product must contain specific ratios, ensuring reliable dosing consistency and distinguishing it from non-standardized supplements.

The extract contains antioxidants that can help improve blood flow by dilating blood vessels, which is a key pharmacological feature of GBE.

General Purpose: What Functions Does Ginkgo Biloba Extract Support?

The extract's overall utility is based on effects which include promoting microcirculation enhancement and offering antioxidant activity. These mechanisms help improve blood flow, notably cerebral blood flow, while providing general neuronal protection. This combined action forms the basis for the extract's general purpose: to help support healthy cognitive enhancement, focusing on aspects such as memory and concentration, and to assist in improving circulatory efficiency in the peripheral blood vessels.

Regulatory References

  1. NCCIH Ginkgo Fact Sheet

What side effects are possible with Gingko Biloba?

Possible side effects and safety information

Standardized Ginkgo biloba extract (GBE) has an officially documented safety profile characterized by both common, generally mild adverse reactions and specific constraints relating to bleeding risk, as detailed in regulatory documents.

Frequency-Classified Adverse Reactions

The most frequently reported adverse reactions are classified as Common (may affect up to 1 in 10 people) and typically involve the nervous system and the gastrointestinal system. These include headache, dizziness, and various gastrointestinal disturbances such as abdominal pain, nausea, or diarrhea. Less common reactions are classified as Uncommon or Rare and often consist of hypersensitivity reactions, such as rash and pruritus.

Serious Safety Constraints and Special Populations

The most significant safety concern documented in regulatory labels relates to the potential for bleeding events, including sporadic reports of spontaneous cerebral or ocular hemorrhage. The frequency of these serious events is typically classified as Not Known or very rare. Consequently, GBE is subject to specific constraints:

  • Pre-Surgical Discontinuation: Official regulatory safety notes advise that the extract should be discontinued several days prior to any surgical procedures to minimize the documented risk of increased bleeding.
  • Contraindications: Use is contraindicated in patients with a pathologically increased bleeding tendency (haemorrhagic diathesis), known hypersensitivity to the extract, and during pregnancy.
  • Cautionary Use: Caution is mandated for patients with epilepsy and those concurrently using other medicines that affect blood clotting, such as anticoagulants or antiplatelet drugs.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Standardized Ginkgo biloba Extract (GBE) focuses on documented serious adverse events rather than a universally reported overdose syndrome. Some national authorities note that no specific human overdose cases have been reported for the standardized leaf extract; however, guidance exists for managing potential over-ingestion.

Documented Risks and Manifestations

Classification Manifestation/Risk
Hemorrhagic Risk Potential for bleeding disorders, including reports of cerebral hemorrhage, ocular, or gastrointestinal bleeding.
Neurological Risk Heightened risk of seizures, particularly in patients with a history of epilepsy.
Common Manifestations Documented signs include headache, dizziness, and gastrointestinal complaints like nausea and diarrhea.

Emergency Actions Mandated by Regulators

If overdosage is suspected, the official required action is to seek immediate medical attention and contact a poison control center or emergency room at once.

Management of over-ingestion is limited to symptomatic and supportive treatment, as no specific antidote for GBE is documented. Urgent medical help is necessary when any severe or life-threatening symptoms, such as significant bleeding or seizure activity, are observed.

Therapeutic Uses of Gingko Biloba

What Ginkgo Biloba Treats: Main Uses and Benefits

Standardized Ginkgo Biloba Extract (GBE) is relevant in contexts involving heightened systemic burden related to cognitive function and circulatory comfort. The use of the extract is considered relevant in areas where short-term symptom management is appropriate, applied in scenarios where additional management of discomfort is required.

GBE is commonly used to help manage symptoms related to mild age-related cognitive impairment, disturbances in concentration, vertigo, and tinnitus, and those associated with conditions presenting with systemic or localized discomfort (e.g., chronic peripheral arterial issues). It is applied in clinical settings that involve recurrent or episodic manifestations of discomfort.

Supportive Domains and Symptom Clusters

GBE is applied in addressing symptom clusters that include a noticeable memory deficit, reduced concentration, or difficulty with mental processing, and supports the patient during difficult episodes by easing distress. The extract is also applied across domains where additional symptomatic support is needed for symptoms related to physical discomfort (e.g., pain in the legs upon walking), which may be linked to minor circulatory issues. It assists with maintaining functional stability and **helps patients cope more steadily with symptom fluctuations.


Quick Fact: Support for Symptoms that Interfere with Daily Functioning
Symptom Cluster Pain in the legs upon walking (Intermittent Claudication)
Associated Benefit Provides support that helps ease the overall symptom burden and supports patients during episodes of heightened discomfort related to mobility.
Use Context Applied in scenarios where additional management of circulatory discomfort is required due to chronic, stable symptoms.

Regulatory References

  1. European Medicines Agency (EMA) Monograph on Ginkgo leaf medicines

Eligibility and Restrictions for Use

Standardized Ginkgo biloba extract (GBE) eligibility is strictly defined by regulatory authorities, with use permitted primarily for adults and the elderly.


Populations for Whom Use is Prohibited or Not Established

Category Regulatory Status (Example Authority)
Contraindicated Pregnant individuals (due to increased bleeding risk); Patients with known hypersensitivity to the extract or excipients.
Not Recommended Children and adolescents under 18 years (due to lack of sufficient data); Breastfeeding individuals.

Conditions Requiring Special Precaution

Official regulatory documents require that GBE only be used under special precaution or after consultation for certain conditions:

  • Patients with a pathologically increased bleeding tendency (haemorrhagic diathesis).
  • Individuals receiving anticoagulant or antiplatelet treatments.
  • Patients with epilepsy, as the product may influence seizure susceptibility.
  • Individuals scheduled for surgery; the product should be discontinued 3 to 4 days prior to the procedure.

These regulatory classifications establish who can safely be considered for use and who must avoid the medicine based entirely on official label text.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents characterize the interaction profile of Ginkgo Biloba extract (GBE) through a combination of pharmacodynamic and pharmacokinetic effects with specific drug classes and substances.

Interaction Scope

Property Value
Medicinal product categories with documented interactions: Anticoagulants, Antiplatelet drugs, Cytochrome P450 (CYP) Substrates, Anticonvulsants.
Specific interacting medicines (if explicitly listed): Warfarin, Aspirin, Clopidogrel, Omeprazole, Nifedipine, Simvastatin, Alprazolam.
Mechanistic basis of interactions (only if stated in label): Pharmacodynamic interaction leading to additive anti-clotting effects; Pharmacokinetic interaction involving CYP enzyme modulation (e.g., induction of CYP2C19, potential modulation of CYP3A4).

Official Interaction Statements

  • Co-administration with Anticoagulants (e.g., Warfarin) and Antiplatelet drugs (e.g., Aspirin) is documented to pose an increased risk of bleeding due to an additive pharmacodynamic effect.
  • GBE is reported to act as an inducer of Cytochrome P450 2C19 (CYP2C19), which may lead to a decrease in the plasma concentration of medicines that are substrates for this enzyme (e.g., Omeprazole).
  • An interaction with Nifedipine is documented, which may cause increased exposure (plasma levels) of Nifedipine.
  • Co-administration may interfere with the action of Anticonvulsants, potentially leading to an increased risk of seizure activity.

Procedural and Restriction Notes

The documented bleeding risk associated with GBE necessitates a procedural constraint: the extract must be discontinued at least two weeks prior to elective surgical or dental procedures. Caution is also required when co-administering GBE with other herbal products or supplements that affect blood coagulation (e.g., Garlic, Ginger) due to a cumulative risk.

Mechanism of Action

The action of Ginkgo biloba involves interaction with multiple biochemical targets, principally mediated by its mathbfterpene lactones (ginkgolides and bilobalide) and mathbfflavone glycosides constituents.

Regulation of Vascular Dynamics and Microcirculation

This domain covers the extract's ability to act as a vasodilator by mathbfenhancing nitric oxide (NO) signaling from endothelial cells, which results in arterial smooth muscle relaxation. The mathbfGinkgolide B component specifically functions as a mathbfPlatelet-Activating Factor (PAF) receptor antagonist, which affects platelet aggregation and thrombus formation. These actions collectively mathbfalter the rate of microcirculatory flow by mathbfmodulating microvascular resistance and mathbfcapillary flow dynamics.

Antioxidant and Cytoprotective Activity

mathbfFlavone glycosides function as mathbffree radical scavengers, directly neutralizing mathbfreactive oxygen species (ROS) and mathbfmodulating the activity of endogenous antioxidant enzymes. This mathbfscavenging of reactive intermediates contributes to the mathbfintegrity of neuronal and mitochondrial membranes.

Neurotransmitter System Modulation

This mechanism focuses on the extract's influence on mathbfsynaptic signaling patterns in the central nervous system. Specific components can affect the metabolism and receptor interaction of key neurotransmitters, including mathbfdopamine, mathbfnorepinephrine, and mathbfacetylcholine. This mathbfmodulation influences the equilibrium of synaptic signaling and mathbfregulates neuronal excitability thresholds.

Dosage and Administration Information

The usage of standardized Ginkgo biloba extract (GBE) is characterized by specific parameters regarding its administration, dose, and duration of use. The extract is available in solid forms, such as tablets and capsules, for the administration of the medicine.


Administration Scope Guideline
Route of administration The medicine is for oral use only.
Dosing schedule The standard daily dose of dry extract is typically in the range of 120 mg to 240 mg.
Timing in relation to meals There are no specific instructions regarding the intake with or without food.
Age-group rules Dosing is designated for adults and the elderly. Use in children and adolescents under 18 years of age is not established and is not recommended.

The total daily dose is intended for administration in 2 to 3 divided doses across the day. This schedule ensures the active constituents—specifically the flavone glycosides and terpene lactones—are delivered according to product standardization requirements.

Course Duration and Procedural Conditions

The treatment course typically lasts for a minimum period of 8 weeks before the regimen's response is assessed. If no symptomatic improvement has occurred, the continuation of the treatment course is generally re-evaluated after 3 months of continuous use. Use beyond certain durations is associated with medical consultation. This structure defines the use of the medicine within a controlled therapeutic cycle.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ginkgo Biloba


Evidence for Use in Age-Related Cognitive Impairment

Standardized Ginkgo Biloba extract was evaluated in studies exploring outcomes in older adults experiencing mild age-related cognitive impairment and symptoms associated with mild-to-moderate dementia. Research includes randomized controlled trials (RCTs) focusing on measuring changes in cognitive function scores, such as memory and processing speed. Findings were mixed; some trials reported measured changes, while larger, longer-term prevention studies were inconsistent regarding observed patterns. The evidence quality varies across studies, and certainty remains low concerning long-term impact or prevention of decline.


Evidence for Use in Circulatory Disorders and Leg Pain

Research was evaluated in studies exploring conditions marked by functional limitations related to circulation, specifically for individuals with chronic peripheral arterial issues. RCTs evaluated functional measures, such as tracking changes in pain-free walking distance. Findings describe patterns observed in the studies over a medium-term duration. For minor symptoms like cold extremities, the evidence is limited to data gathered from its long-standing traditional use, and scientific reviews have noted that some foundational evidence quality varies across studies due to methodological issues.


Evidence for Use in Vertigo and Tinnitus

Ginkgo Biloba was studied for its application in conditions associated with fluctuating or episodic manifestations, specifically vertigo (dizziness) and tinnitus (ringing in the ears). Research in this area has resulted in mixed findings across RCTs, which monitored changes in the reported intensity of symptoms. The available evidence base is limited, and scientific reviews have consistently noted inconsistencies in the results. This inconsistency is noted in scientific reviews and may be linked to heterogeneity in how outcomes were measured.


Evidence in Specific Populations

Studies were also evaluated in healthy adults who did not have a diagnosis of cognitive impairment. Research in this population examined specific functions like memory and attention. Findings indicated that effects observed were associated with non-significant measurements on key cognitive performance tasks for these healthy groups. Overall, results apply only to the populations studied.


What Remains Uncertain and Areas for Future Research

A significant limitation across the research is the variability across studies, particularly for cognitive function. Long-term effects are not fully established for most uses, and comparative evidence is lacking in some areas. Research is ongoing, particularly to fill gaps where data for certain groups remain insufficient.

Key Studies & References

  1. Ginkgo biloba for intermittent claudication (Cochrane Review)

Frequently Asked Questions (FAQ)

Common questions about Ginkgo Biloba (FAQ)


Q: Can Ginkgo Biloba be taken with blood pressure medicine?

A: Official product information indicates a potential interaction with certain blood pressure lowering medicines, such as Nifedipine. This interaction may result in an increase in the blood levels of the blood pressure medicine. Official information suggests caution and monitoring when these medicines are used together.


Q: Are there any common foods or drinks that interact with Ginkgo Biloba?

A: Regulatory documents advise caution regarding the consumption of alcohol while using Ginkgo Biloba due to reports of a potential disulfiram-like reaction. Official warnings state that the raw or roasted seeds of the Ginkgo plant are toxic and are not for ingestion.


Q: What is the difference between Ginkgo Biloba extract and the raw leaf?

A: The extract used in medicinal products is a standardized product, meaning it is chemically processed to contain a precise, consistent percentage of active components like flavonol glycosides. This standardization ensures purity and minimal levels of potentially harmful compounds, such as ginkgolic acids. The raw leaf or unprocessed plant parts lack this controlled standardization and may contain higher levels of potentially harmful compounds.


Q: Do older adults need to be more careful about using Ginkgo Biloba?

A: Official regulatory information designates the product for use in both adults and the elderly. While this is the intended user group, general caution is advised for all patients, especially regarding the risk of interactions with concurrent medications. Older adults are generally encouraged to be cautious due to potential susceptibility to interaction risks, as noted in general warnings.


Q: Can women who are pregnant or breastfeeding use Ginkgo Biloba?

A: According to official product labels, use of Ginkgo Biloba is contraindicated, or strongly advised against, during pregnancy. Official product information notes that safety and efficacy data regarding use during breastfeeding are currently unpublished.


Q: Does Ginkgo Biloba interact with common pain relievers like ibuprofen?

A: Official warnings indicate that combining Ginkgo Biloba with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which includes common pain relievers like Ibuprofen, may pose an increased risk. This combination is associated with an additive effect, potentially increasing the risk of bleeding.


Q: Is there a maximum amount of time a person should take Ginkgo Biloba?

A: There is no single, universally established maximum duration for using Ginkgo Biloba extract. Clinical studies have examined the safe use of the extract in adults for periods of up to six years. The recommended treatment protocol suggests that a healthcare professional reassess the continuation of use after a minimum three-month period.


Q: Are there different forms of Ginkgo Biloba supplements (pills, liquid, tea)?

A: Standardized Ginkgo Biloba extract is manufactured into several different forms for oral use. These commonly include tablets and capsules, as well as liquid or powder extracts. Some forms of tea are also available.


Q: Are there any reported interactions between Ginkgo Biloba and certain herbal teas?

A: Official information suggests caution when combining Ginkgo Biloba with other herbal products, particularly those known to affect blood clotting. While specific data is sparse for most common herbal teas, some research has explored potential interactions with products like Green Tea.


Q: Are there specific countries where Ginkgo Biloba is approved for certain treatments?

A: Yes, the regulatory status of Ginkgo Biloba extract varies globally. In several countries, particularly within Europe, a standardized extract such as EGb 761 is formally approved as a medicine. This approval is for the treatment of symptoms associated with conditions like cognitive decline, peripheral circulatory disorders, tinnitus, and vertigo.


Q: Does Ginkgo Biloba interact with antidepressants or mood stabilizers?

A: Official regulatory reports indicate a potential for interaction between Ginkgo Biloba and certain central nervous system (CNS) medications, including some antidepressants like Trazodone or Amitriptyline. This combination may be associated with a potential reduction in the antidepressant’s effectiveness or an increased risk of seizure activity.


Q: Can Ginkgo Biloba interfere with the effects of vitamins or other supplements?

A: Ginkgo Biloba contains a substance called Ginkgotoxin, which has been investigated for potential antagonism with Vitamin B6 (pyridoxine). Official documents suggest caution and monitoring when the extract is combined with any other vitamins or supplements.


Q: What is the difference between EGb 761 and other Ginkgo extracts?

A: EGb 761 is the trade name for a specific, highly controlled extract that is used as a reference for clinical studies and in medicinal products worldwide. It is differentiated from general extracts because it adheres to a highly precise formula, containing specific controlled levels of flavonoid glycosides and terpene lactones.


Q: Does taking Ginkgo Biloba affect my ability to drive or operate machines?

A: Although there is no specific blanket warning against operating machinery, official documentation lists dizziness and headache as common side effects. Official labels state that patients should monitor their individual response before engaging in activities that require mental alertness, such as driving.


Q: Has Ginkgo Biloba been studied for its use in eye conditions?

A: Research has examined the potential role of Ginkgo Biloba extract in certain eye conditions. These studies have specifically explored the extract's ability to protect against retinal degenerative diseases and improve ocular blood flow in conditions like Normal-Tension Glaucoma (NTG).


Q: Can Ginkgo Biloba affect sleep patterns, making you more or less sleepy?

A: The most frequently reported side effects do not typically include changes to sleep patterns like general drowsiness. However, official safety data has documented rare adverse event reports, such as those related to obstructive sleep apnoea syndrome.


Q: What does the research say about Ginkgo Biloba and anxiety or stress?

A: While not a primary approved use, research has explored the anti-stress potential of Ginkgo Biloba extract. Studies in this area have specifically focused on its observed effects on stress response pathways and certain neurotransmitter systems.


Q: Does Ginkgo Biloba have an impact on blood sugar levels?

A: Official drug interaction information highlights that Ginkgo Biloba may potentially interact with diabetes medications. If used alongside diabetes medications, professional monitoring of blood sugar levels is necessary, as there is a potential for a change in glucose response.


Q: What is the typical timeframe for reported side effects after starting Ginkgo?

A: According to analysis from adverse event reports, the median timeframe for the onset of reported side effects is typically 7 days after starting treatment. The data suggests that most reactions are reported within the first week of using the product.


Q: Can someone who is vegetarian or vegan use most Ginkgo Biloba products?

A: The active ingredient in Ginkgo Biloba extract is derived from the plant's leaves, making the active substance itself plant-based. However, the composition of the capsule, tablets, or other delivery forms may vary. Individuals can refer to the product label for specific confirmation that the product uses vegan-friendly ingredients.


Q: Why is the Ginkgo seed or fruit often considered toxic?

A: The raw or roasted seeds and the surrounding fruit pulp are considered toxic because they contain compounds such as the neurotoxin Ginkgotoxin (4'-O-methylpyridoxine). These toxic substances are associated with the risk of poisoning.


Q: Are there any interactions with common over-the-counter cold medicines?

A: Official regulatory guidance advises general caution when combining Ginkgo Biloba with any medications, including those purchased over-the-counter (OTC) for cold symptoms. This general caution is due to the potential for drug-drug interactions.


How should Gingko Biloba be stored and disposed of?

The storage and disposal of standardized Ginkgo Biloba Extract (GBE) must adhere strictly to conditions outlined in regulatory labeling to maintain product quality and ensure safety.

Storage and Protection

The product must be kept in a cool dark place and protected from light and heat. To maintain integrity, the container cap must be closed tightly after use, and the product must not be used if the cap seal is broken or missing. As a mandatory safety requirement, the medicine must be stored out of reach of children.

Disposal Requirements

Official instructions require that unused, expired, or unwanted contents and containers must be disposed of in accordance with local regulation. This ensures compliance with pharmaceutical waste standards and prevents environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Gingko Biloba found in:

A-Z Index: